REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001187443-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
100
Total Value
$77,852.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $775.63 | $775.63 | 17,902 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 10 | $776.59 | $7,765.90 | 17,892 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 57 | $777.56 | $44,320.92 | 17,835 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 12 | $778.53 | $9,342.36 | 17,823 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 5 | $779.41 | $3,897.05 | 17,818 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $780.09 | $780.09 | 17,817 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 5 | $781.48 | $3,907.40 | 17,812 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $782.53 | $782.53 | 17,811 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 3 | $783.34 | $2,350.02 | 17,808 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $784.59 | $784.59 | 17,807 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $785.71 | $785.71 | 17,806 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 2 | $786.29 | $1,572.58 | 17,804 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 9, 2026 | Sale | 1 | $787.82 | $787.82 | 17,803 | Direct | โ | View Details |